SI1044680T1 - Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate - Google Patents

Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate

Info

Publication number
SI1044680T1
SI1044680T1 SI200030183T SI200030183T SI1044680T1 SI 1044680 T1 SI1044680 T1 SI 1044680T1 SI 200030183 T SI200030183 T SI 200030183T SI 200030183 T SI200030183 T SI 200030183T SI 1044680 T1 SI1044680 T1 SI 1044680T1
Authority
SI
Slovenia
Prior art keywords
amoxycillin
treatment
novel method
dosage regimen
high dosage
Prior art date
Application number
SI200030183T
Other languages
English (en)
Slovenian (sl)
Inventor
Kevin Storm
Creighton Conley
John Roush
Original Assignee
Beecham Pharmaceuticals (Pte) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1044680(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Pharmaceuticals (Pte) Limited filed Critical Beecham Pharmaceuticals (Pte) Limited
Publication of SI1044680T1 publication Critical patent/SI1044680T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
SI200030183T 1999-04-13 2000-04-11 Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate SI1044680T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12907499P 1999-04-13 1999-04-13
US15072799P 1999-08-25 1999-08-25
US15981399P 1999-10-15 1999-10-15
EP00303033A EP1044680B1 (en) 1999-04-13 2000-04-11 Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate

Publications (1)

Publication Number Publication Date
SI1044680T1 true SI1044680T1 (en) 2003-12-31

Family

ID=27383840

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200030183T SI1044680T1 (en) 1999-04-13 2000-04-11 Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
SI200000097A SI20304A (sl) 1999-04-13 2000-04-11 Formulacija za modificirano sproščanje, ki obsega amoksicilin in kalijev klavulanat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200000097A SI20304A (sl) 1999-04-13 2000-04-11 Formulacija za modificirano sproščanje, ki obsega amoksicilin in kalijev klavulanat

Country Status (45)

Country Link
EP (4) EP1044680B1 (fi)
JP (2) JP4880125B2 (fi)
KR (1) KR100634937B1 (fi)
CN (1) CN100382782C (fi)
AP (1) AP1806A (fi)
AR (1) AR031068A1 (fi)
AT (2) AT4327U1 (fi)
AU (1) AU767177B2 (fi)
BE (2) BE1013309A5 (fi)
BG (1) BG65006B1 (fi)
BR (1) BRPI0009719B8 (fi)
CA (1) CA2366304C (fi)
CO (1) CO5170471A1 (fi)
CZ (1) CZ298801B6 (fi)
DE (3) DE10017883A1 (fi)
DK (3) DK200000602A (fi)
DZ (1) DZ3150A1 (fi)
EA (1) EA004310B1 (fi)
ES (2) ES2190692B1 (fi)
FI (2) FI20000863A (fi)
FR (1) FR2792198A1 (fi)
GB (1) GB2351661B (fi)
GR (1) GR1003560B (fi)
HK (1) HK1032741A1 (fi)
HU (1) HU229097B1 (fi)
IE (1) IE20000271A1 (fi)
IL (2) IL145580A0 (fi)
IT (1) ITMI20000788A1 (fi)
MA (1) MA25352A1 (fi)
MX (1) MXPA01010377A (fi)
MY (1) MY119953A (fi)
NL (2) NL1014914C1 (fi)
NO (1) NO329694B1 (fi)
NZ (1) NZ514575A (fi)
OA (1) OA11926A (fi)
PE (1) PE20010053A1 (fi)
PL (1) PL197448B1 (fi)
PT (2) PT102450B (fi)
RO (1) RO120817B1 (fi)
SE (1) SE0001330L (fi)
SI (2) SI1044680T1 (fi)
SK (1) SK285140B6 (fi)
TR (1) TR200102963T2 (fi)
TW (1) TWI235067B (fi)
WO (1) WO2000061116A2 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
IL123563A (en) 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
CA2452872A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
WO2003084518A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
JP2005528383A (ja) * 2002-04-10 2005-09-22 ミラー，フレッド，エイチ． 多重相・複数コンパートメントカプセルシステム
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1541129A1 (en) * 2003-12-12 2005-06-15 Cimex AG Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (en) * 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
EP2079453A1 (en) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co. Robust sustained release formulations
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
MX2017012877A (es) 2015-04-07 2018-07-06 Church & Dwight Co Inc Composiciones gomosas de multicomponentes con nucleo suave.
CN109394718B (zh) * 2018-11-15 2021-04-27 石药集团中诺药业（石家庄）有限公司 一种阿莫西林分散片及其制备方法
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP0680322B1 (en) * 1993-01-22 2000-07-05 Smithkline Beecham Plc Use of clavulanate and an antibacterial compound for the treatment of infections
GB9311030D0 (en) * 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (it) * 1994-06-06 1995-12-06 Smithkline Beecham Farma Formulazioni farmaceutiche
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
IL123563A (en) * 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
ATE243516T1 (de) * 1997-02-14 2003-07-15 Glaxosmithkline Lab Sas Amoxicillin und clavulanat enthaltende arzneizubereitungen
CA2283467A1 (en) * 1997-03-11 1998-09-17 Almag Al Process and apparatus for coating metals
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
ID22340A (id) * 1997-03-25 1999-09-30 Takeda Chemical Industries Ltd Komposisi farmasi lekat-mukosa saluran pencernaan
JP3746901B2 (ja) * 1997-10-15 2006-02-22 ユニ・チャーム株式会社 開閉自在容器
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Also Published As

Publication number Publication date
FR2792198A1 (fr) 2000-10-20
FI20000863A (fi) 2000-10-13
CZ298801B6 (cs) 2008-02-06
AU767177B2 (en) 2003-11-06
AU5702000A (en) 2000-11-14
ES2190692A1 (es) 2003-08-01
PT1044680E (pt) 2003-10-31
HK1032741A1 (en) 2001-08-03
CN1382040A (zh) 2002-11-27
BRPI0009719B8 (pt) 2021-05-25
FI20000863A0 (fi) 2000-04-11
RO120817B1 (ro) 2006-08-30
JP2011256180A (ja) 2011-12-22
FIU20000164U0 (fi) 2000-04-11
AP1806A (en) 2007-12-14
MXPA01010377A (es) 2002-10-23
SI20304A (sl) 2001-02-28
BG104329A (en) 2001-11-30
NZ514575A (en) 2004-05-28
JP4880125B2 (ja) 2012-02-22
OA11926A (en) 2006-04-12
ES2202004T3 (es) 2004-04-01
EP1044680A1 (en) 2000-10-18
BG65006B1 (bg) 2006-12-29
NO20001870L (no) 2000-10-16
DE60003255D1 (de) 2003-07-17
PL197448B1 (pl) 2008-03-31
SK285140B6 (sk) 2006-07-07
KR100634937B1 (ko) 2006-10-17
NO329694B1 (no) 2010-12-06
MY119953A (en) 2005-08-30
PE20010053A1 (es) 2001-03-10
EP1269997A1 (en) 2003-01-02
PT102450B (pt) 2003-09-30
PT102450A (pt) 2001-02-01
NL1014914C1 (nl) 2000-10-16
SE0001330L (sv) 2000-10-14
HU229097B1 (en) 2013-07-29
EP1270005A2 (en) 2003-01-02
DK200000133U3 (da) 2000-07-28
SK5342000A3 (en) 2000-11-07
IL145580A0 (en) 2002-11-10
CA2366304C (en) 2004-06-29
CA2366304A1 (en) 2000-10-19
EP1270005A3 (en) 2006-05-17
WO2000061116A3 (en) 2001-02-01
IL145580A (en) 2007-05-15
NL1014915A1 (nl) 2000-10-16
AR031068A1 (es) 2003-09-10
DK200000602A (da) 2000-10-14
ATE242629T1 (de) 2003-06-15
EP1269996A1 (en) 2003-01-02
DE20006626U1 (de) 2000-10-19
CZ20001311A3 (cs) 2000-11-15
SE0001330D0 (sv) 2000-04-11
WO2000061116A2 (en) 2000-10-19
GB0008923D0 (en) 2000-05-31
NO20001870D0 (no) 2000-04-11
TR200102963T2 (tr) 2002-02-21
GR1003560B (el) 2001-03-16
ES2190692B1 (es) 2004-11-16
BR0009719A (pt) 2002-01-08
DE60003255T2 (de) 2004-05-06
HU0001471D0 (en) 2000-06-28
ITMI20000788A1 (it) 2001-10-11
PL339591A1 (en) 2000-10-23
KR20020015312A (ko) 2002-02-27
ITMI20000788A0 (it) 2000-04-11
DZ3150A1 (fr) 2000-10-19
DE10017883A1 (de) 2000-10-26
CN100382782C (zh) 2008-04-23
EA200101075A1 (ru) 2002-04-25
HUP0001471A3 (en) 2001-10-29
AP2001002284A0 (en) 2001-12-31
IE20000271A1 (en) 2001-04-04
DK1044680T3 (da) 2003-09-29
EA004310B1 (ru) 2004-02-26
BE1012733A6 (fr) 2001-02-06
EP1044680B1 (en) 2003-06-11
NL1014915C2 (nl) 2001-02-12
GB2351661B (en) 2001-10-10
CO5170471A1 (es) 2002-06-27
BE1013309A5 (fr) 2001-11-06
AT4327U1 (de) 2001-06-25
HUP0001471A2 (en) 2001-03-28
BR0009719B1 (pt) 2014-09-30
FI4823U1 (fi) 2001-02-16
GB2351661A (en) 2001-01-10
MA25352A1 (fr) 2001-12-31
JP2002541187A (ja) 2002-12-03
TWI235067B (en) 2005-07-01

Similar Documents

Publication Publication Date Title
HK1032741A1 (en) Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
HK1050992A1 (zh) 含有藥物配方的阿莫西林和克拉維酸
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU3777597A (en) Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
AU3917400A (en) Athletic apparatus and method of use
HUP9801064A3 (en) Composition comprising amoxycillin and clavulanic acid
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU5739499A (en) Pharmaceutical formulation of sodium amoxycillin and potassium clavulanate
AUPQ582400A0 (en) A method of treatment and agents for use therein
AU2001226609A1 (en) Method and formulation for treatment of vasoconstriction
SG99857A1 (en) A method of treatment and prophylaxis
AU781936C (en) A method of treatment and agents useful for same
AUPQ065299A0 (en) A method of prophylaxis and treatment and agents useful for same
EP1225912A4 (en) PROPHYLAXIS AND TREATMENT PROCESS
AUPQ656500A0 (en) A method of treatment and agents for same
AU4385200A (en) A method of prophylaxis and treatment and agents useful therefor
AUPQ021999A0 (en) A method of prophylaxis and treatment and agents useful therefor
AUPP865899A0 (en) A method of treatment and agents useful for same
AUPQ124899A0 (en) A method of treatment and agents useful for same
AUPP937799A0 (en) A method of prophylaxis and treatment
AUPQ362799A0 (en) A method of prophylaxis and treatment
AUPQ022099A0 (en) A method of prophylaxis and treatment
AU2493301A (en) A method of therapy and prophylaxis of inflammation
AUPQ645500A0 (en) A method of treatment and agents useful for same